The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global positron emission tomography market grew at CAGR of around 6% during 2014-2019. Positron emission tomography (PET) is a combination of nuclear medicine and biochemical analysis that is utilized for measuring the metabolic activity of cells. It functions by administering a small amount of radioactive glucose (sugar) into the vein of the patient through an intravenous (IV) line. A scanner and computer then generate detailed pictures of areas containing the glucose, which helps in evaluating the functions of organs and tissues effectively. Consequently, PET is utilized as an effective solution in the early detection of cancer, heart diseases and brain disorders as compared to other imaging techniques. Nowadays, it is used along with computed tomography (CT) and magnetic resonance imaging (MRI) scans to assist in the diagnosis of lung cancer, epilepsy, Alzheimer's disease and coronary artery disease.
At present, the market is experiencing growth on account of the sudden outbreak of the coronavirus disease (COVID-19). PET assists in the study of the pathogenesis of infectious diseases and the development and assessment of novel therapeutics. Other than this, the growing number of people who have cancer, neurological disorders and cardiovascular diseases, represent another key factor impelling the global PET market growth. Moreover, the increasing adoption of hybrid imaging techniques, along with the reimbursements provided by governments of several countries, is creating opportunities for PET scanner manufacturers. Furthermore, the clinical trials, such as radiotherapy planning based on fluoro-deoxyglucose positron emission tomography (FDG-PET), are expected to drive the market significantly in the upcoming years. Looking forward, IMARC Group expects the global positron emission tomography market to exhibit moderate growth during the next five years.
Breakup by Type:
Breakup by Detector Type:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Agfa Healthcare (Dedalus Group), GE Healthcare, Koninklijke Philips NV, Neusoft Medical Systems, Positron Corporation, Oncovision (Bruker), Mediso Medical Imaging Systems Ltd., Siemens Healthineers AG, Segami Corporation, Hitachi Ltd., etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at